Title: U.S. General Anesthesia Drugs Market Worth $2 Billion by 2020
1U.S. General Anesthesia Drugs Market Worth 2
Billion by 2020
www.MarketsandMarkets.com
2According to a new market research report "U.S.
General Anesthesia Drugs Market by Molecule
(Propofol, Benzodiazepines, ketamine(s()
ketamine HCl), Methohexital Sodium), route of
administration (Intravenous, Inhalational),
Supply Chain (GPOs, Distributors), Competitive -
Analysis Forecast to 2020",published by
MarketsandMarkets, The U.S. General Anesthesia
Drugs Market is expected to reach around 2
Billionby 2020 at a CAGR of 3.8 from 2015 to
2020.
3Browse 42 market data Tables and 28 Figures
spread through 114 Pages and in-depth TOC
on "U.S. General Anesthesia Drugs
Market http//www.marketsandmarkets.com/Market-R
eports/anesthesia-drugs-ketamine-market-713.html
Early buyers will receive 10 customization on
this report. The U.S. general anesthesia drugs
market is poised to reach USD 2.0 billion by
2020 from USD 1.6 billion in 2015, at a CAGR of
3.8 from 2015 to 2020. Factors such as rapid
rise in aging population, rising prevalence of
cardiovascular and respiratory system-related
diseases, and rising number of emergency
surgeries are driving the growth of the U.S.
general anesthesia drugs market. However, side
effects associated with ketamine usage (such as
elevation in blood pressure and heart rate,
amnesia, respiratory depression, and
hallucinations), regulatory issues, and lower
compliance rates in comparison with other
anesthetic drugs are likely to restrain the
growth of this market.
4The market is segmented on the basis of molecule
and route of administration. On the basis of
molecules, the market is divided into Propofol,
Benzodiazepine, Ketamine (S-()-Ketamine HCL),
and Methohexital Sodium. Propofol is expected to
be fastest-growing segment, owing to its greater
preference and rapid onset of action. On the
basis of route of administration, the U.S.
general anesthesia drugs market is bifurcated
into intravenous and inhalational. The
intravenous segment is expected to account for
the largest share of the U.S. general anesthesia
drugs market in 2015. Greater patient compliance
and less number of side effects as compared to
inhalational anesthetics are driving the growth
of this market. A complete brochure for
this research is available _at_ http//www.marketsand
markets.com/pdfdownload.asp?id713
5- Market Segmentation
- The report segments the U.S. general anesthesia
drugs market into the following segments - By Route of Administration
- Intravenous
- Inhalational
- By Molecule
- Propofol
- Benzodiazepine (Midazolam and Diazepam)
- Ketamine (Esketamine hydrochloride or
S-()-Ketamine hydrochloride) - Methohexital Sodium
- Major players operating in the U.S. General
Anesthesia Drugs Market are AstraZeneca plc
(U.K.), Baxter International Inc. (U.S.), Hikma
Pharmaceuticals PLC (U.K.), Mylan N.V. (U.S.),
Eisai Co., Ltd. (Japan), Fresenius Se Co. KGaA
(Germany), Hospira, Inc. (U.S.), and Par
Pharmaceutical Companies, Inc. (U.S.).
6Browse Related Reports Operating Room
Management Market by Product (Data Management,
Anesthesia, Surgical, Performance), Application
(Perioperative, Preoperative, OR Scheduling),
Component (Software, Services), Delivery Mode
(Web-Based, On-Premise) Global Forecast to
2019 http//www.marketsandmarkets.com/Market-Repor
ts/operating-room-management-market-175407912.htm
7About Report Publisher MarketsandMarkets is
the worlds No. 2 firm in terms of annually
published premium market research reports.
Serving 1700 global fortune enterprises with more
than 1200 premium studies in a year, MM is
catering to a multitude of clients across 8
different industrial verticals. We specialize in
consulting assignments and business research
across high growth markets, cutting edge
technologies and newer applications.
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence
repository. Annual Market Research Reports
Subscription - http//www.marketsandmarkets.com/Su
bscription.html Contact Mr. Rohan Markets and
Markets UNIT no 802, Tower no. 7, SEZ Magarpatta
city, Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441